I have all the data needed. Here is the complete clinical analysis:
Patient Clinical Summary - Sabiha
Patient Demographics
- Name: Sabiha
- Age: 32 years old
- Gender: Female
- DOB: 06 June 1992
- Address: Mardan, Pakistan
- Date of Admission: 02 July 2026
Primary Diagnosis on Admission
Right-sided septated pleural effusion + Asthma
Clinical History
Background
- Known asthmatic - currently on Combiair 400/12 mcg (Formoterol + Budesonide combination inhaler)
- History of recurrent chest infections
- 1 month prior she was admitted to the same hospital for right-sided pneumothorax - underwent therapeutic aspiration at that time
Presenting Complaints (Current Admission)
- Cough
- Fever - on/off
- Right-sided pleuritic chest pain
- Chest congestion
- Weight loss
- Anorexia
- TB Contact positive (she has had known exposure to a TB patient)
Vitals on Admission
| Parameter | Value | Significance |
|---|
| SpO₂ | 95% (on room air) | Mildly reduced - normal ≥98% |
| Pulse | 80/min | Normal |
| Temperature | 100°F | Low-grade fever |
| BP | 110/85 mmHg | Normal |
| SpO₂ (on 03/07) | 94% | Slightly worsening hypoxia |
| PR (on 03/07) | 75 bpm | Normal |
Examination Findings
GPE: No jaundice, no anemia (clinically), no cyanosis, no clubbing, no koilonychia, no lymphadenopathy, no edema, no thyroid swelling.
CNS: Oriented to time, place, and person.
CVS: S1 + S2 audible, no murmurs.
Abdomen: Soft, non-tender.
Respiratory (Key Findings):
- Bilateral wheeze (consistent with underlying asthma)
- Decreased breath sounds on the right side - consistent with the right-sided pleural effusion
- Pleural fluid R/E (routine examination) - Done
Laboratory Results - Analysis
Chemical Pathology
| Parameter | Normal | 24-May-26 | 02-Jul-26 | Interpretation |
|---|
| RBS | 80-150 mg/dL | 118 | 100 | Normal |
| Creatinine | 0.7-1.2 mg/dL | 0.78 | 0.73 | Normal - kidneys fine |
| Blood Urea | 10-50 mg/dL | 31 | 32 | Normal |
| ALT | 5-55 U/L | 9 | 8 | Normal |
| ALKP | 40-150 U/L | 68 | 57 | Normal |
| Bilirubin | 0.2-1.2 mg/dL | 0.3 | 0.3 | Normal |
| Albumin | 3.5-5.2 g/dL | 4.6 | 4.1 | Normal (slight decline) |
| GGT | 9-64 U/L | 16 | 17 | Normal |
Liver and kidney function are normal. Albumin slightly declining over time, which can be seen with chronic illness/poor nutrition.
Hematology - Trend Analysis (Critical)
| Parameter | Normal | 23-May | 24-May | 26-May | 02-Jul | Interpretation |
|---|
| HB | 14-17 g/dL | 13.7 | 13.8 | 11.3 | 11.4 | Low - mild anemia |
| MCV | 76-90 fL | 72.4 | 72.5 | 70.1 | 74.3 | Low - microcytic |
| MCH | 25-31 pg | 22.1 | 21.6 | 21.8 | 22.9 | Low - hypochromic |
| WBC | 4-11 × 10³/uL | 29.2 | 13.1 | 13.1 | 12.8 | Was severely elevated, now trending down |
| NEU% | 40-70% | 81.6 | 87.9 | 85.8 | 50.8 | Was significantly elevated (bacterial response), now normalizing |
| LYM% | 20-40% | 8.7 | 7.8 | 13.8 | 35.7 | Was low (lymphopenia), now recovering |
| Abs Lym | 1-3 × 10³/uL | 2.5 | 1.0 | 1.8 | 4.6 | Now elevated - lymphocytosis |
| PLT | 150-400 × 10³/uL | 327 | 356 | 303 | 340 | Normal throughout |
| RDW | 11.5-12.5 | 10.4 | 10.3 | 12.8 | 13.9 | Elevated - anisocytosis (mixed anemia) |
Key blood picture interpretation:
- The WBC of 29,200 on 23-May was severely elevated - this represents a major acute bacterial/inflammatory response (possibly pneumothorax-related infection or empyema)
- The shift from neutrophilia → lymphocytosis over time is important and can be seen with:
- Resolving bacterial infection + superimposed TB (TB tends to produce lymphocytosis)
- Treatment response
- Microcytic hypochromic anemia (low Hb, MCV, MCH with elevated RDW) is consistent with iron deficiency anemia - commonly seen with chronic disease and anorexia
- Abs Neutrophils (23.8 on 23-May → 6.5 on 02-Jul) confirms the dramatic fall in neutrophil count - treatment is working
Clinical Impression
Most Likely Diagnosis: Pulmonary Tuberculosis with Tuberculous Pleural Effusion (Right-sided, Septated)
Evidence supporting TB:
- TB contact positive - stated explicitly in the progress note
- Symptoms classic for TB: chronic cough, fever (on/off), weight loss, anorexia
- Right-sided septated pleural effusion - septation is characteristic of TB or complicated parapneumonic effusion
- Prior pneumothorax - spontaneous pneumothorax in young adults can be the first presentation of apical TB
- Lymphocyte shift in recent CBC - TB pleural effusions classically show lymphocyte predominance
- Microcytic anemia - consistent with chronic disease/TB
- Recurrent chest infections in a young woman - TB must always be at the top of the differential in endemic areas like Mardan, KPK, Pakistan
- The consultant noted "TB-Contact +" specifically in the progress notes
Co-existing Condition: Bronchial Asthma
- Already on Combiair (budesonide/formoterol)
- Bilateral wheeze on examination
- B/L wheeze can also have a component from TB endobronchial involvement
Management Plan (As Documented)
From the admission plan:
- Admit to pulmonology ward
- CXR (PA view) - chest X-ray
- Ultrasound chest - to characterize the effusion better and guide drainage
- Sputum GeneXpert (MTB/RIF) - rapid molecular test for TB - this is the key diagnostic test
- CBC, RFTs, LFTs, RBS - baseline labs (already done)
- Pleural fluid R/E - already done as of 03/07 round
From 03/07/26 consultant round order (partially visible):
- "Pleural fluid R/E - Done"
- "Chest: B/L wheeze, Decrease air entry (Right)"
- "CVS: S1S2+0"
- Plan includes Sips + O₂ (likely sips of fluids + oxygen therapy)
Summary Table
| Domain | Finding |
|---|
| Age/Sex | 32-year-old female |
| Core diagnosis | Rt septated pleural effusion, likely TB |
| Background | Known asthmatic, recurrent chest infections |
| Prior admission | Rt pneumothorax 1 month ago (aspirated) |
| TB risk | Contact positive, endemic region (Mardan, Pakistan) |
| O₂ saturation | 94-95% on room air (mildly hypoxic) |
| Blood picture | Resolving leukocytosis, microcytic anemia, lymphocyte recovery |
| Liver/Kidney | Completely normal |
| Key pending test | Sputum GeneXpert result |
Disclaimer: This is an AI-assisted summary for educational/clinical support purposes only. All management decisions must be made by the treating physician. The patient requires formal microbiological confirmation (GeneXpert, pleural fluid ADA, culture) before initiating anti-TB therapy (HRZE regimen).